Threshold Pharmaceuticals Announces Reverse Stock Split -
Threshold Pharmaceuticals Inc names Dr. Herbert Hurwitz to scientific advisory board -
Dr. Herbert Hurwitz Joins Scientific Advisory Board At Threshold -
Threshold reports positive results from Phase I study of tumor drug -
Threshold Pharmaceuticals Announces $18 Million Private Equity Financing -
THLD: To Transfer Listing to NASDAQ Capital Market on Tuesday, June 17 -
Threshold Pharmaceuticals' Request to Transfer to NASDAQ Capital Market Approved -
THLD: Receives Nasdaq Delisting Notice re Minimum Bid Price Rule -
Threshold Pharmaceuticals Received Anticipated NASDAQ Staff Determination Letter -
THLD: To Present At AACR Annual Meeting Conference @ 16:00 ET [delayed] -
THLD: To Present At AACR Annual Meeting Conference @ 16:00 ET [delayed] -
Threshold Pharmaceuticals Inc. (THLD) Corporate Event Announcement Notice -
Threshold Pharmaceuticals Inc. (THLD) Corporate Event Announcement Notice -
Threshold Pharmaceuticals Inc. (THLD) Corporate Event Announcement Notice -
Page 1 of 1
1 Previous | Next
|